Marcus A. Neubauer

Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology

Nasser H. Hanna, Marcus A. Neubauer, Constantin T. Yiannoutsos et al. · Journal of Clinical Oncology · 2008 · 496 citations

Medicine, Oncology, Radiation Oncology +15

Phase III Study of Iniparib Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer

Joyce O’Shaughnessy, Lee Schwartzberg, Michael A. Danso et al. · Journal of Clinical Oncology · 2014 · 305 citations · Full text

Medicine, Oncology, Pharmacology +15

Randomized Phase II Trial of Erlotinib With and Without Entinostat in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed on Prior Chemotherapy

Samir E. Witta, Robert M. Jotte, Katrik Konduri et al. · Journal of Clinical Oncology · 2012 · 195 citations · Full text

Medicine, Oncology, Pharmacology +17

Cost Effectiveness of Evidence-Based Treatment Guidelines for the Treatment of Non–Small-Cell Lung Cancer in the Community Setting

Marcus A. Neubauer, J. Russell Hoverman, Michael Kolodziej et al. · Journal of Oncology Practice · 2010 · 173 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +13

Lack of Correlation between Epidermal Growth Factor Receptor Status and Response to Panitumumab Monotherapy in Metastatic Colorectal Cancer

J. Randolph Hecht, Edith P. Mitchell, Marcus A. Neubauer et al. · Clinical Cancer Research · 2010 · 108 citations

Medicine, Oncology, Pharmacology +17